@article{7abbc2844c3d4918aba001ffa229e0de,
title = "Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance",
author = "Isenor, {Jennifer E.} and Kervin, {Melissa S.} and Halperin, {Donna M.} and Joanne Langley and Bettinger, {Julie A.} and Top, {Karina A.} and Fawziah Lalji and Kathryn Slayter and Janusz Kaczorowski and Bowles, {Susan K.} and Waite, {Nancy M.} and Halperin, {Scott A.} and Beth Taylor and Shelly McNeil",
note = "Funding Information: The Improve ACCESS Team reports grant funding from GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN) and through Collaborative Research Agreements with GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. The authors acknowledge the generous in-kind support provided by the participating community pharmacies for waiving the injection fee for the Tdap vaccine and Neighbourhood Pharmacy Association of Canada. The authors thank the dedicated pharmacists and pharmacy staff whose tremendous efforts make this study possible. Finally, we thank the following additional members of The Improve ACCESS Team: Beth Taylor and Shelly McNeil. This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Funding Information: This work was supported by the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN), GlaxoSmithKline Biologicals SA and Sanofi Pasteur Limited. All supporters were provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. ",
year = "2020",
month = mar,
day = "1",
doi = "10.1177/1715163519900221",
language = "English",
volume = "153",
pages = "88--94",
journal = "Canadian Pharmacists Journal",
issn = "1715-1635",
publisher = "Canadian Pharmacists Association",
number = "2",
}
